Close Menu

You may find more results for this query on our sister sites: GenomeWeb and Precision Oncology News.

Home › Business, Policy & Funding › Business News › Curetis 2017 Revenues Down 8 Percent

Curetis 2017 Revenues Down 8 Percent

Apr 30, 2018
|
staff reporter

NEW YORK (GenomeWeb) – Curetis today posted an 8 percent year-over-year drop in 2017 revenues as an increase in sales of test cartridges for its Unyvero molecular diagnostic instrument was offset by a decline in system and service sales.

For the year ended Dec. 31, 2017, Curetis' revenues fell to €1.2 million ($1.4 million) from €1.3 million in 2016. Cartridge sales in 2017 were €736,000 versus €573,000 the year before, while instrument and service sales fell to €465,000 from €738,000.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Apr
29
Featured Webinar

A New Generation of PCR: At-home Testing and Preparing for Emerging Strains of COVID-19

Sponsored by
Co-Diagnostics

Join Dr. Heather Fehling, Chief Scientific Officer at Clinical Reference Labs (CRL), as she provides some insights regarding the future applications of PCR testing.

May
13
Featured Webinar

Limits of Detection Matter: New Challenges for SARS-CoV-2 Diagnostics and COVID-19 Patient Management

Sponsored by
LGC SeraCare Life Sciences

As we pass the one-year anniversary of both the COVID-19 pandemic and the first Emergency Use Authorized SARS-CoV-2 PCR detection assays, there remains significant opportunity for clinical laboratories to advance testing and support improved patient management.

May
18
Featured Webinar

Put Your Money Where Your Mouth Is: Tracking and Attacking COVID-19 through State-Wide Saliva Surveillance

Sponsored by
Bio-Rad

This webinar will present the details of a COVID-19 saliva screening program that has been implemented at more than 90 different colleges, universities, private schools, and nursing homes across New York state.  

What's Popular?

In Molecular Diagnostics

  1. NIH Funds $33M in COVID-19 Testing Projects for Safe Return of Students, Staff to School

  2. With Luminex Acquisition, DiaSorin to Broaden MDx Portfolio, Expand US Presence

    Premium

  3. Color Health, Yale Get FDA Emergency Use Authorization for Coronavirus Sample Collection Kits

  4. Labs Craft SARS-CoV-2 Variant Genotyping Assays for Screening, Surveillance

    Premium

  5. Scope Fluidics Gets CE Mark for Rapid MRSA MDx Panel

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2021 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.